Who owns the KANAPH THERAPEUTICS INC. trademark?

The KANAPH THERAPEUTICS INC. trademark is owned by Kanaph Therapeutics Inc..

What class is the KANAPH THERAPEUTICS INC. trademark registered in?

The KANAPH THERAPEUTICS INC. trademark is registered in Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

What is the serial number for KANAPH THERAPEUTICS INC.?

The USPTO serial number for KANAPH THERAPEUTICS INC. is 98391050.

What is the registration number for KANAPH THERAPEUTICS INC.?

KANAPH THERAPEUTICS INC. is registered under USPTO registration number 7650919.

KAN

USPTO Trademark Record

REGISTERED

KANAPH THERAPEUTICS INC.

SN 98391050·Reg 7650919·Filed Feb 05, 2024

Owner Kanaph Therapeutics Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

KANAPH THERAPEUTICS INC. (Serial No. 98391050), Registration No. 7650919, is a registered US trademark filed on Feb 05, 2024 by Kanaph Therapeutics Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

early section 8: January 14, 2031

Mark Intelligence

KANAPH THERAPEUTICS INC. (Reg. #7650919) is a registered US trademark that has been protecting its owner, Kanaph Therapeutics Inc., since 2024. The mark covers Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 05, 2024

SERIAL

98391050

REG#

7650919

REGISTERED

Jan 14, 2025

Owner

Applicant

Kanaph Therapeutics Inc.

Entity

Corporation

Address

5F, 3 Itaewon-ro 55ga-gil, Yongsan-gu, Seoul, 04348

Country

Attorney

NameRichard Y. Kim

Law firm

Richard Y. Kim SNELL & WILMER L.L.P.

Docket

80946.39000

Address

ONE EAST WASHINGTON STREET, SUITE 2700, PHOENIX, AZ 85004-2556, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 05, 2024

Serial Number98391050

Registration No.7650919

Registration DateJan 14, 2025

Status DateJan 14, 2025

Published for OppositionNov 26, 2024

Mark TypeDesign with words

Attorney Docket80946.39000

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

20 events

REGISTERED-PRINCIPAL REGISTER

Jan 14, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 14, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Nov 26, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 26, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 20, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Nov 04, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Nov 04, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 04, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Nov 04, 2024

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 04, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 28, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 28, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 28, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Aug 29, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 29, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 29, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Aug 28, 2024

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Mar 13, 2024

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 12, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 08, 2024

NEW APPLICATION ENTERED

KANAPH THERAPEUTICS INC.

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Kanaph Therapeutics Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Richard Y. Kim

Resources

Company